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Summary
After viral infection, activated T cells are present in
multiple tissues regardless of the infection route.
How these cells acquire pleiotropic homing ability is
unclear. By using a cutaneous vaccinia virus infection
model,wedemonstrate that regulationofTcell traffick-
ing is multiphasic. Upon completion of three cell divi-
sions, CD8+ T cells upregulated specific skin-homing
molecules within draining lymph nodes (LN). By 60 hr
after infection, some activated T cells reached the
infected tissue, while others entered distant antigen-
free LN. These latter cells continued to divide and ac-
quire additional tissue-homing molecules in this new
setting, independent of antigen presentation. After
viral clearance, the initial skin-homing imprint became
the predominant homing phenotype on memory cells
and provided superior protection against secondary
cutaneouschallenge.Theseobservationsdemonstrate
a mechanism by which T cells provide both immediate
tissue-specific immune control at the pathogen entry
site and a more flexible systemic protection against
pathogen dissemination.
Introduction
Like most pathogens, viruses typically invade hosts via
epithelial interfaces between body and environment.
The immune system must both rapidly and efficiently
target the tissue of pathogen entry to control the infec-
tion in situ, while at the same time protect distant tissues
against dissemination of the pathogen. Accordingly, in
mouse models, large numbers of effector and memory
T cells have been found in all extralymphoid tissues
examined after intravenous infection with vesicular sto-
matitis virus, demonstrating a highly versatile ability of
activated T cells to infiltrate different tertiary tissues
(Masopust et al., 2001). The ubiquitous presence of
effector and memory T cells in multiple tissues after
pathogen infection has also been observed after oral
infection with Listeria monocytogenes or rotavirus, as
well as intranasal infection with Sendai virus (Masopust
et al., 2001, 2004). These observations appear to sug-
gest that the anatomic site of pathogen infection, and
thus site of initial T cell activation, does not predict the
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partners.org (T.S.K.)subsequent tissue-specific homing of activated T cells;
rather, acute microbial infection invariably leads to sys-
temic dissemination of antigen-experienced T cells. The
logic of this event is clear, because these T cells can act
as sentinels in all extralymphoid tissues upon secondary
infection or dissemination of the primary infection. One
clinical correlate of this idea is the well-documented
fact that epicutaneous inoculation of vaccinia virus
(VV) by skin scarification successfully protects people
against variola virus infection, which typically occurs
via intranasal and oropharyngeal exposure (Lane, 1977).
How T cells acquire this ability to home indiscrimin-
ately to multiple peripheral tissues after localized infec-
tion remains obscure. For example, it has now become
clear that T cell migration between different body com-
partments is a highly regulated process. One current
paradigm states that T cell trafficking is controlled by
the sequential interactions of adhesion molecules and
chemokine receptors that are differentially expressed
on various T cell subsets and their target tissues (Kunkel
and Butcher, 2002; von Andrian and Mackay, 2000).
Naive and central memory T cells (Tcm) predominantly
circulate among secondary lymphoid organs (SLO),
where they make extensive contacts with professional
antigen-presenting cells (Weninger and von Andrian,
2003). These cells express high levels of L-selectin
(CD62L) and chemokine (C-C motif) receptor 7 (CCR7)
required for optimal lymph nodes (LN) entry (Springer,
1994; Warnock et al., 1998; Weninger et al., 2001). Effec-
tor memory T cells (Tem) isolated from skin express
specific chemokine receptors such as CCR4 and E-se-
lectin ligands (E-Lig) such as cutaneous lymphocyte
antigen in human, while those from small intestine pref-
erentially express a4b7 integrin and CCR9 (Campbell
and Butcher, 2002; Campbell et al., 1999; Erdmann et al.,
2002; Fuhlbrigge et al., 1997; Kunkel et al., 2000). Recent
studies with cell-associated antigen models demon-
strated that T cells activated in regional lymphoid nodes
(LN) are programmed to express homing molecules spe-
cific to the site of the immunization (Calzascia et al.,
2005; Dudda et al., 2004). This appears to be at odds
with the observations from the infection models outlined
above. Since rotavirus has a narrowly defined tissue tro-
pism and wild-type Sendai virus is exclusively pneumo-
tropic in mice (Bass et al., 1990; Tashiro et al., 1990), it is
highly unlikely that the ubiquitous presence of activated
T cells after local infections results from disseminated
infection and T cell activation in multiple SLO.
To understand more clearly how T cells develop pleio-
tropic tissue-homing ability during immune response
to local microbial infection, we studied the tissue-
homing phenotype and the trafficking pattern of anti-
gen-specific T cells at a series of time points after VV
infection by two distinct routes—cutaneous inoculation
by skin scarification and intraperitoneal (i.p.) injection.
By using recombinant VV expressing the ovalbumin
peptide OVA257-264 (rVV-ova) and adoptive transfer of
OVA257-264-specific CD8
+ T cells from OT-I TCR trans-
genic mice, we demonstrated multiphasic regulation
of T cell trafficking during primary response. At the early
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512stage of immune response, activated T cells were im-
printed with tissue-specific homing phenotype upon
completion of three cell division cycles within regional
LN. By 60 hr after infection, some of these cells migrated
specifically into infected tissues, while other activated
T cells that have divided at least three times also mi-
grated to distant lymphoid tissues that drain uninfected
organs. Unexpectedly, these latter T cells acquired ad-
ditional and distinct tissue-homing imprinting molecules
in distant LN, a process that occurs independent of
additional antigen activation. Thus, after localized viral
infection and T cell priming in localized draining lymph
nodes, multiple homing imprinting programs can occur
on the activated T cells circulating in different LN micro-
environments independent of subsequent systemic
antigen presentation. After viral clearance, the initial
homing imprint became the predominant, although not
the sole, homing phenotype on memory CD8+ T cells
present in all SLO. Importantly, this ‘‘memory’’ of the
immunization site provides superior protection against
secondary challenge via the same route. Taken to-
gether, our observations demonstrate a plausible mech-
anism by which T cells provide both immediate tissue-
specific immune control at pathogen entry site and
a more flexible systemic protection against pathogen
dissemination.
Results
Antigen-Specific CD8+ T Cells Were Activated in LN
Draining the Infected Tissues after Cutaneous
or Intraperitoneal VV Infection
To study the trafficking of activated T cells in a physiolog-
ical viral infection setting, we infected C57B/l6 (B6) mice
with VV epicutaneously by skin scarification, a technique
widely used to vaccinate humans against smallpox (Bre-
man and Henderson, 2002; Lane, 1977). After VV inocula-
tion near the base of the tail, the infected mice developed
a characteristic skin ‘‘pox’’ lesion at the inoculation site
(see Figure S1 in the Supplemental Data available online).
The temporal evolution of the lesion from vesicle, to pus-
tule, and then to healing crust, closely resembled that
of lesions developed by human vaccinees (http://www.
bt.cdc.gov/agent/smallpox/vaccination/facts.asp). To
track the in vivo activation, proliferation, and trafficking
of antigen-specific CD8+ T cells after VV infection, we
adoptively transferred Thy1.1+ naive CD8+ T cells from
OT-I T cell receptor (TCR) transgenic mice (OT-I cells)
into Thy1.2+ B6 mice 24 hr prior to scarification with
VV-ova (Norbury et al., 2002). Before transfer, OT-I cells
were labeled with carboxy-fluorescein diacetate succini-
midyl ester (CFSE). To compare cutaneous viral inocula-
tion with infection involving a distinct anatomic tissue,
additional groups of mice were infected with rVV-ova
by i.p. injection.
At 60 hr postinfection, various secondary lymphoid
organs, including inguinal LN (ILN), mesenteric LN
(MLN), cervical LN (CLN), brachial LN (BLN), and spleen,
were harvested and examined individually for OT-I cell
activation. In skin-scarified mice, OT-I cells that had un-
dergone up to seven rounds of proliferation were easily
detected in ILN that drained the infected skin area
(Figure 1A). No proliferating OT-I cells were found in
LN draining other tissues, although a small number ofdividing OT-I cells were also found in the spleen. In con-
trast, after i.p. infection, the most vigorous proliferation
observed in MLN and spleen (Figure 1B), while some
activated OT-I cells were detected in all the lymphoid
tissues examined. This is consistent with the establish-
ment of VV infection involving both the visceral and
parietal peritoneum. Together, these results identified
ILN and MLN as the major LN for CD8+ T cell activation
after skin scarification and i.p. infection, respectively.
Tissue-Specific Homing Phenotype Was Imprinted
on Activated T Cells in Regional LN within 60 hr
of Infection
We next analyzed the expression of homing molecules
on the activated OT-I cells in ILN or MLN at 60 hr after
skin scarification or i.p. infection with rVV-ova, respec-
tively. OT-I cells displayed a naive phenotype (CD62Lhi,
E-Lig2, P-Lig2, a4b72) in ILN (Figure 2A), MLN, and
spleen (data not shown) of uninfected control mice. In
contrast, CD62L was strongly downregulated on a sig-
nificant number of proliferating OT-I cells after both
cutaneous and i.p. infected groups at this time point
(Figures 2B and 2C). Concurrently, there was a strong
upregulation of the skin-homing molecules E-Lig and
P-Lig on the majority of proliferating OT-I cells in ILN
of scarified mice, as detected by the specific binding
to E-selectin and P-selectin-Ig chimera protein (Fig-
ure 2B). The a4b7 was not upregulated on proliferating
OT-I cells in ILN of skin-scarified mice. In contrast, after
i.p. infection, a4b7 was strongly upregulated on prolifer-
ating OT-1 cells in MLN, while expression of E-Lig and
P-Lig were not induced significantly (Figure 2C). Inter-
estingly, the downregulation of CD62L and upregulation
of CD11a occurred early on after T cell activation and
reached a plateau level by the third cell division, while
the upregulation of the tissue-homing molecules a4b7,
E-Lig, and P-Lig occurred primarily on T cells that had
divided more than three times and continued to increase
until the seventh cycle of division (Figures 2B–2D).
To test whether it is the route of infection or the site of
T cell priming that regulates the early expression of tis-
sue-specific homing molecules, we examined the hom-
ing molecule expression of OT-I cells activated in ILN
of i.p. infected mice at the same time point (Figure 1B).
Similar to those activated in ILN of skin-scarified mice,
Figure 1. CD8+ T Cell Activation Was Initiated in ILN after Tail Skin
Scarification with rVV-ova
CFSE-labeled naive Thy1.1+ OT-1 cells were transferred into Thy1.2+
B6 mice. Recipient mice were then infected with rVV-ova by either
(A) skin scarification or (B) i.p. injection. 60 hr after the infection,
proliferation of OT-I cells in ILN, BLN, CLN, MLN, and spleen were
analyzed by flow cytometry. Histograms were gated on Thy1.1+
donor cells and are representative of six independent experiments.
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513these cells upregulated skin-homing molecules E-lig
and P-lig, but not the gut-homing molecule a4b7
(Figure S2), suggesting that the homing phenotype of
activated T cells is imprinted by LN-specific factors
rather than the infection route. Together, these data
provide strong evidence that very early after infection,
activated CD8+ T cells are programmed to express tis-
sue-specific homing phenotype within draining LN. Im-
printing of homing phenotype occurs subsequent to
the T cell activation, as shown by the fact that OT-I cells
in MLN of either uninfected or skin-scarified mice did not
express a4b7 and maintained a naive phenotype (data
not shown).
Activated T Cells Homed Specifically to Infected
Peripheral Tissues within 60 hr
Having shown that activated CD8+ T cells acquired
tissue-specific homing molecules within draining LN
60 hr after viral infection, we asked whether the in vivo
Figure 2. The LN of T Cell Activation Imprints Differential Expression
of Skin or Gut-Homing Molecules on CD8+ T Cells as Early as 60 hr
after Infection
CFSE-labeled Thy1.1+ OT-I cells were adoptively transferred into
Thy1.2+ B6 mice.
(A) At 7 days after transfer, the phenotype of OT-I cells in ILN of naive
recipient mice was analyzed by flow cytometry. Dot plots were gated
on viable lymphocytes.
(B and C) ILN of skin-scarified mice (B) and MLN of i.p. infected mice
(C) wereharvestedat60hr after rVV-ova infection.The activation, pro-
liferation, and tissue-homing phenotype of OT-I cells were analyzed
by flow cytometry. Dot plots were gated on Thy1.1+ cells. The num-
bers in quadrant indicate the percentages in Thy1.1+ population.
(D) The geometric mean fluorescence intensities (GMFI) of the indi-
cated markers on OT-I cells were plotted with the cell division
cycles. Filled circles, ILN of scarified mice; unfilled circles, MLN of
i.p. mice. Data are representative of six independent experiments.homing preference of these T cells is consistent with
their phenotype. Peritoneal lavages and tail skin sam-
ples were examined for the presence of T cells. As
shown in Figure 3A, significant numbers of Thy1.1+ do-
nor OT-I cells were present in peritoneal lavage of the
i.p. infected, but not skin-scarified, mice at 60 hr after
infection. Interestingly, the Thy1.1+ cells in peritoneal
cavity of the i.p. infected mice had completed more
cell division cycles, with the majority of these cells hav-
ing divided 7–9 times, as compared to cells in MLN hav-
ing divided on average 5–7 times at the same time point
(Figure 3B). Few if any cells in the first three division
cycles were found in peritoneal cavity. Peritoneal OT-I
cells expressed high level of a4b7 and were CD62Llow
(data not shown). These data suggest that the ability to
home to nonlymphoid locations (e.g., peritoneal cavity)
increases in parallel with increasing rounds of cell divi-
sion and acquisition of tissue-specific homing mole-
cules. It is possible, however, that effector T cells were
recruited to peritoneal cavity nonspecifically by inflam-
matory signals rather than the interactions between
the tissue-homing molecules. To test this possibility,
we infected OT-I recipient mice simultaneously with
rVV-ova by skin scarification and with wild-type VV (no
ova antigen) by i.p. injection. At 60 hr after the infections,
OT-I cells were activated and proliferating in ILN, but few
OT-I cells were found in peritoneal cavity even in the
presence of viral peritonitis (Figure S3). This result sug-
gests that, at this early time point, T cell trafficking is
predominantly directed by the tissue-specific homing
receptors rather than inflammatory signals. We also
investigated T cell homing into skin after VV infection
Figure 3. In Vivo Tissue-Selective Homing of Activated CD8+ T Cells
at 60 hr after VV Infection
(A) Peritoneal lavage of mice infected with rVV-ova by scarification or
i.p. injection were analyzed for the presence of OT-I cells.
(B) Proliferation of OT-I cells in peritoneal cavity (solid line) or MLN
(dotted line) of i.p. infected mice was analyzed by CFSE signals.
Data are representative of two to four independent experiments.
(C and D) Tail skin samples were prepared at 60 hr after (C) skin scar-
ification or (D) i.p. infection with rVV-ova. Slides of frozen tissue were
stained with anti-CD3 mAb. Scale bars represent 50 mm.
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issues precluding us from harvesting sufficient cells to
perform flow cytometry on this tissue. While very few T
cells were found in tail skin samples at 60 hr after i.p.
infection, significant infiltration of CD3 T cells was noted
in the epidermal and dermal layers of the inoculated area
in skin-scarified mice (Figures 3C and 3D). Collectively,
these results demonstrate that activated CD8+ T cells
imprinted with tissue-homing phenotype specifically
Figure 4. At Day 5 after Skin Scarification with rVV-ova, Activated
OT-I Cells Had Disseminated throughout SLO and Entered Perito-
neal Cavity without Concurrent Systemic Viral Infection
(A) Lymphocytes were prepared from the indicated tissues 5 days
after rVV-ova skin scarification. The proliferation of OT-I cells was
analyzed by flow cytometry.
(B) RNA samples were prepared from the indicated tissues at day 5
after VV scarification. VV infection was measured by real-time RT-
PCR. Data represent the averages 6 SD of four independent exper-
iments with three mice per group.
(C) Antigen-presenting cells were purified with anti-MHC Class II
magnetic beads from ILN, MLN, and spleen of B6 mice 4 days after
skin scarification with rVV-ova. The cells were cocultured with
CFSE-labeled Thy1.1+ OT-I cells for 60 hr. OT-I cell activation and
proliferation was monitored by flow cytometer. The histograms
were gated on Thy1.1+ population. Data are representative of two
independent experiments.targeted the infected tissues early on during primary
response against viral infection.
OT-I Cells Activated in ILN Disseminate through
Distant LN by Day 5 of VV Skin Scarification
We next examined various LNs and spleen for the pres-
ence of activated Thy1.1+ OT-I cells at later time points
after skin scarification with rVV-ova. In contrast to the
highly polarized tissue-specific migration seen at 60 hr
after infection, proliferating OT-I cells were found in all
SLO examined at day 5 after VV skin scarification
(Figure 4A). Notably, while donor T cells in the first three
proliferation cycles (OT-I P1-3) were present in ILN as
three distinct populations, these cells were barely de-
tectable in other LN and spleen. The lack of OT-I P1-3 in
distant LN was further illustrated by the increased ratios
of OT-I cells in more advanced cell cycles (OT-I P>3) to
OT-I P1-3 in distant lymphoid tissues than in ILN (data
not shown). CFSE2 OT-I cells were also found in perito-
neal cavity 5 days after skin scarification, although to
a much lesser extent than i.p. infected mice (4.07% 6
0.23% versus 22.1% 6 0.078% of Thy1.1+ cells in total
peritoneal lavage cells) (Figure 4A and data not shown).
Therefore, in contrast to the tissue-specific trafficking at
60 hr after VV infection, at 5 days after skin scarification,
activated CD8+ T cells that have divided more than three
times in ILN appeared to have disseminated throughout
secondary lymphoid organs and reached peripheral
sites that were not initially infected by the viruses.
We considered the possibility that cutaneous inocula-
tion of VV may have led to viremia and subsequent sys-
temic antigen expression, leading to antigen-driven T
cell proliferation in LNs distant from the site of initial in-
fection. To test this, we measured the expression of an
early VV gene in different tissues at day 5 after skin
scarification by real-time RT-PCR. As expected, abun-
dant VV mRNA was detected in tail skin samples
(Figure 4B). While there was a low and barely detectable
level of viral gene transcription in ILN, this highly sensi-
tive real-time RT-PCR approach failed to detect any viral
gene expression in intestine, MLN, or spleen. Further-
more, antigen-presenting cells (MHC class II+ cells) pu-
rified from MLN and spleen on day 4 after rVV-ova
skin scarification failed to induce OT-I cell proliferation
in vitro (Figure 4C). These data provide strong evidence
against a systemic viral infection and/or viral antigen
presentation as an explanation for the presence of divid-
ing T cells in distinct LN. Taken together, our results in-
dicate that subsets of activated OT-I cells can leave
draining LN after three rounds of cell division and mi-
grate either to the peripheral tissue for which they ex-
press homing receptors or to remote LN where they
continue to divide in an antigen-independent fashion.
Disseminated OT-I Cells Acquired Additional
HomingMolecules in Various LNMicroenvironments
while Maintaining Their Initial Tissue-Homing
Imprinting
To study the tissue-homing phenotype of OT-I cells after
their dissemination, cells from various SLO were har-
vested at 5 days post skin scarification and stained for
the expression of selectin ligands and integrin a4b7. At
this time point, both E-Lig and P-Lig were highly ex-
pressed on OT-I cells present in ILN, MLN, and spleen
CD8+ T Cell Trafficking after Viral Infection
515(Figure 5A). Therefore, the early skin-homing imprint
within ILN is maintained on OT-I cells after they have
reached distant lymphoid tissues. Unexpectedly, how-
ever, the gut-homing molecule a4b7 was also expressed
on a significant portion of OT-I cells in all lymphoid tis-
sues examined, although the level of expression was
significantly lower than that in i.p. infected mice (GMFI
were 49.1 and 318, respectively, Figure 5A and data
not shown). Furthermore, while most of the OT-I cells ex-
pressing tissue-specific homing phenotype were either
E-lig+ or a4b7+, a significant fraction of these cells ex-
pressed both molecules. The expression of a4b7 on
OT-I cells in skin-scarified mice suggested one of two
possibilities: either activated T cells spontaneously be-
gan to acquire homing molecules for multiple tissues
as the immune response progressed, or alternatively,
they received additional tissue-homing imprinting sig-
Figure 5. At Day 5 after Skin Scarification with rVV-ova, the Gut-
Homing Molecule a4b7 Was Upregulated on Disseminated OT-1
CD8+ T Cells
(A) ILN, MLN, and spleen were harvested at day 5 after scarification
with rVV-ova. The expression of the indicated homing markers on
Thy1.1+ OT-I cells was determined by flow cytometry. Dot plots
were gated on Thy1.1+ cells and are representative of five indepen-
dent experiments. Numbers in quadrants indicate percentages in
Thy1.1+ population.
(B–D) B6 mice that had received Thy1.1+ OT-I cells were given daily
injections of FTY720 starting 24 hr before scarification with rVV-ova.
On day 5 after infection, lymphocytes from the indicated SLO were
harvested and analyzed by flow cytometry.
(B) The percentages of Thy1.1+ cells in total lymphocytes. Black
bars, FTY720-treated mice; unfilled bars, untreated mice. Data rep-
resent the average 6 SD of six mice from three independent exper-
iments.
(C and D) The expression of E-Lig (C) and a4b7 (D) on OT-I cells in
ILN. Histograms were gated on Thy1.1+ populations and are repre-
sentative of three independent experiments. Solid lines, FTY720-
treated mice; dotted lines, untreated mice.nals in the new LN microenvironment after their dis-
semination. To distinguish between these two possibil-
ities, we attempted to block the egress of lymphocytes
from ILN after skin scarification by daily administration
of FTY720 (2-amino-2-(2[4-octylphenyl]ethyl)-1,3-pro-
panediol hydrochloride) starting 24 hr before rVV-ova
skin scarification. FTY720 is a functional antagonist of
sphingosine 1-phosphate (S1P) that regulates lympho-
cyte egress from lymphoid tissues. Administration of
FTY720 induces lymphocytopenia via sequestration of
lymphocytes in LN without affecting their activation
and function (Matloubian et al., 2004; Pinschewer
et al., 2000). As expected, the number of Thy1.1+ cells
was significantly increased in ILN of skin-scarified
FTY720-treated mice, as compared to the numbers in
untreated mice on day 5 after infection (Figure 5B). At
the same time, there were significantly fewer Thy1.1+
cells in MLN and spleen in skin-scarified FTY720-treated
mice, and these cells were undivided according to the
CFSE signals (Figure 5B and data not shown). Subse-
quent phenotyping of cells trapped in the ILN by
FTY720 revealed similar levels of E-Lig expression on
OT-I cells in ILN of FTY720 treatment and untreated
mice (Figure 5C). However, treatment with FTY720 com-
pletely blocked the expression of a4b7 on OT-I cells in
the ILN (Figure 5D). Meanwhile, FTY720 treatment of
i.p. infected mice did not block the expression of a4b7
on OT-I cells activated in MLN (Figure S4). Therefore, it
is highly unlikely that the lack of a4b7 expression on
OT-I cells in Figure 5D is due to an inhibitory effect of
FTY720 on a4b7 upregulation. These data suggest that
the upregulation of gut-homing molecules is a facilitated
process that occurred after (and as a result of) activated
CD8+ T cells circulated through gut-draining LN, rather
than a spontaneous development independent of their
LN microenvironment.
Recently, it was shown that high-number monospe-
cific T cell transfer may artificially alter both the develop-
ment of activated T cells and their homing receptor
expression (Marzo et al., 2005). Specifically, CD62L is
aberrantly retained on T cells activated at high precursor
frequency. This could significantly affect their in vivo
homing preference. To study whether the observed
CD8+ T cell dissemination and subsequent acquisition
of additional homing molecules also occur in physiolog-
ical condition or are rather associated with the CD62Lhi
OT-I cells generated in the high number cell-transfer set-
ting, experiments with low input cell numbers (5 3 103
OT-I cells per mouse) were performed. At 60 hr post
rVV-ova skin scarification or i.p. injection, OT-I cells
were activated in ILN or MLN, respectively (Figure S5).
Consistent with our findings with higher input cell num-
bers, there was a significant upregulation of E-Lig on
ILN-activated OT-I cells (Figure S5A), while a4b7 was
upregulated on MLN-activated OT-I cells (Figure S5B).
However, in contrast to Figure 2, with the lower input
number of OT-I cells, virtually all the OT-I cells became
CD62Llow. Importantly, 5 days after rVV-ova skin scarifi-
cation, activated OT-I cells were found in all the lym-
phoid tissues examined, including MLN and spleen. A
subset of OT-I cells had acquired gut-homing molecule
a4b7 after disseminating into MLN (Figure S6). This is,
again, consistent with the observations with higher input
OT-I cell number. Therefore, the findings that locally
Immunity
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lymphoid tissues and acquire new homing phenotype
are recapitulated at a more physiological setting.
After Viral Clearance, the Predominant Homing
Phenotype on Memory CD8+ T Cells Reflected
the Initial Route of Viral Inoculation
We have shown that activated OT-I cells were initially
programmed within the draining LN to express tissue-
homing molecules specific for the site of infection (Fig-
ures 2 and 3) but acquired additional homing molecules
as a result of subsequent internodal migration (Figure 5).
We then asked which set of tissue-homing molecules
would persist on memory CD8+ T cells at a time point
well after the infection had been cleared. We therefore
determined the expression of tissue-homing molecules
on Thy1.1+ memory OT-I cells at day 30 after VV infec-
tion, either by skin scarification or i.p. injection. At this
time point, the frequencies of Thy1.1+ cells had reached
equilibrium among all LN examined in both groups of
mice (Figures 6A and 6B). Importantly, in skin-scarified
mice, while the frequency of a4b7+ OT-I cells had re-
duced to the baseline level similar to 60 hr post infection,
more than 30% of the memory OT-I cells in ILN ex-
pressed E-Lig, and a significant portion of memory OT-
I cells in MLN and spleen were also E-Lig+ (Figures 6C
and 6D). In both ILN and MLN, the frequency of memory
Figure 6. The Imprint of Tissue-Specific Homing Molecule Expres-
sion during Acute Viral Infection Was Maintained during the Memory
Phase
Lymphocytes were harvested from the indicated SLO at 60 hr (A
and C) or day 30 (B and D) after rVV-ova infection. OT-I cells were
identified by Thy1.1 staining and analyzed by flow cytometry.
(A and B) The percentages of Thy1.1+ OT-I cells in total cell popula-
tion.
(C and D) The percentages of E-Lig+ or a4b7+ cells in Thy1.1+ donor
cells. Data represent the average 6 SD of six mice in two indepen-
dent experiments.cells with skin-homing markers is significantly higher
than that of gut-homing memory cells (Figure 6D). In
contrast, in i.p. infected mice, significant portions of
memory OT-I cells expressed a4b7 in all SLO (Figure 6D).
Therefore, it appears that the initial, rather than the sec-
ondary, imprinting of tissue-selective homing molecules
seen on activated CD8+ T cells has become predomi-
nant on memory CD8+ T cells present throughout SLO
long after the viral clearance.
Skin Scarification Provides Superior Protection
against Secondary Cutaneous Viral Challenge
than i.p. Immunization
We have shown that skin- or gut-homing molecules are
preferentially maintained on memory CD8+ T cells in
scarified or i.p. immunized mice, respectively. To be
meaningful, however, it is important to determine
whether this leads to more effective protection of the
previously exposed tissues against secondary chal-
lenge. To address this question, mice immunized previ-
ously with rVV-ova either by skin scarification or i.p. in-
jection were challenged with rVV-ova infection by skin
scarification. A group of unimmunized mice were also
infected as controls. At day 6 after challenge, the skin
samples were harvested from the VV inoculation site
and viral DNA copy number was measured by real-
time PCR. As shown in Figure 7, viral DNA was undetect-
able at the skin site of secondary challenge in all the
mice previously immunized by skin scarification, while
significant viral DNA could be detected at the skin chal-
lenge site in 4 out of 6 mice previously immunized via
an intraperitoneal route. As expected, samples from
unimmunized mice had the highest viral load (more
than 2 logs higher than that of i.p. immunized group).
These results demonstrate that immunization via skin
scarification provides demonstrably superior protection
Figure 7. Skin-Scarified Memory Mice Were Better Protected
against Secondary Cutaneous Viral Challenge than i.p. Immunized
Mice
B6 mice were immunized with rVV-ova either by skin scarification or
i.p. injection. 4 weeks later, the mice were challenged with 2 3 106
pfu rVV-ova by skin scarification. A group of unimmunized mice
were also infected at the same time. 6 days after the viral challenge,
skin samples were harvested from the inoculated area and virus
loads were determined by quantitative real-time PCR. Data repre-
sent the average 6 SD of four to seven mice in one experiment.
CD8+ T Cell Trafficking after Viral Infection
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i.p. immunization.
Discussion
Trafficking of activated T cells among different body
compartments is central for the host immune response
against microbial infection. Recent studies have demon-
strated that virus-specific effector and memory T cells
are present ubiquitously in a wide range of host tissues
regardless of the route of viral infection (Masopust et al.,
2001, 2004). It is unclear when and how these cells ac-
quire the ability to enter multiple tissues. In the current
study, by using VV infection established at two distinct
sites, we demonstrate a multiphasic regulation of T
cell trafficking during the immune response. After VV
skin scarification or i.p. infection, CD8+ T cells are acti-
vated and begin to proliferate within lymphoid tissues
draining the infected tissues. Along with cell division,
there is convincing upregulation of E-Lig and P-Lig,
but not a4b7, on OT-I cells in skin-draining LN of skin-
scarified mice, while i.p. infection results in upregulation
of a4b7 but not E-Lig or P-Lig on OT-I cells in the visceral
peritoneal-draining MLN. T cells activated and educated
in these LN appear to specifically migrate into the in-
fected extralymphoid tissues as early as 60 hr after viral
inoculation.
Activated OT-I cells also migrated into distant anti-
gen-free lymphoid tissues, likely after three cell divi-
sions, and continued to proliferate. This is consistent
with the previous report that naive CD8+ T cells are acti-
vated by antigenic encounter, and that they will continue
to divide and differentiate in the absence of further anti-
genic stimulation (Kaech and Ahmed, 2001). Remark-
ably, by day 5 post infection, they had begun to acquire
additional homing receptors that appeared to be im-
printed in their new LN microenvironment. That is, T cells
originally activated in ILN of skin-scarified mice ex-
pressed a4b7 after entering MLN; these cells could
then traffic back to ILN through blood. This was not an
artifactual consequence of the high number of OT-1
cells present, since these findings are held true even
when small number of (5 3 103) OT-I cells were adop-
tively transferred into hosts. Migration of ILN-activated
OT-I cells to MLN and the subsequent acquisition of
a4b7 could be blocked by FTY720 treatment, which pre-
vented activated T cells from leaving ILN. The observa-
tion that CD62Llow OT-I cells entered LN efficiently, as
shown by us as well as others (Kassiotis and Stockinger,
2004; Marzo et al., 2005), is surprising since CD62L is
thought to be required for T cell LN homing. The mech-
anism for CD62L-independent LN homing of activated
CD8+ T cells remains to be elucidated. To our knowl-
edge, this study represents the first in vivo evidence
suggesting that after localized infection, while T cell
priming occurs rapidly in LN draining the infected tis-
sues, multiple homing-imprinting programs can be ac-
quired by activated T cells circulating through different
LN microenvironments, a process independent of anti-
gen presentation. Therefore, T cell priming and homing
receptor acquisition are sequential, but not obligately
coupled, independent processes that can occur in re-
mote anatomical locations.The current paradigm of homing imprinting empha-
sizes the role of DC in determining the T cell trafficking
tropism. When stimulated in vitro with antigen-pulsed
DC isolated from MLN or PP, CD8+ T cells upregulated
a4b7 and CCR9; in contrast, activated T cells expressed
P-Lig and E-Lig when cultured with DC from skin-
draining LN (Johansson-Lindbom et al., 2003; Mora
et al., 2003; Stagg et al., 2002). These studies suggest
that homing signals are provided by tissue-specific DC
during antigen presentation. However, based on our ob-
servation that gut-homing molecules can be induced on
activated CD8+ T cells migrating from ILN to antigen-free
MLN, we propose that homing signals produced by tis-
sue-specific DC and stromal cells may be present con-
stitutively in regional LN. Thus, they can act in trans on
circulating T cells that were recently activated through
the TCR elsewhere, allowing multiple homing imprinting
programs to be received by the same T cells at different
times. For example, it was recently discovered that ret-
inoic acid produced by intestinal DC signals activated T
cells for a4b7 and CCR9 expression (Iwata et al., 2004).
The presence of higher levels of retinoic acid in MLN
may contribute to the secondary gut-homing molecule
expression on ILN-stimulated T cells. In support of
this, it was demonstrated that after injection of DC via
different routes, T cells activated in regional LN ex-
pressed homing receptors specific for the injected tis-
sues, irrespective of the DC origin (Dudda et al., 2005).
Imprinting of multiple homing pathways on activated
T cells has been reported recently, but in a distinct ex-
perimental setting (Calzascia et al., 2005). When mice
were injected with tumor cells subcutaneously and intra-
peritoneally at the same time, CD8+ T cells with either
skin- or gut-homing phenotype (but not both) were
found in skin-draining LN 4 days after tumor implanta-
tion. The authors postulated that CD8+ T cells specific
for the i.p. implanted tumors were imprinted with gut-
homing phenotype in skin-draining LN and concluded
that the site of antigen entry, rather than the identity of
LN where T cell are activated, is responsible for the hom-
ing phenotype. Our findings in the present study allow
for a different interpretation of these data. While skin-
homing OT-I cells were present in MLN at day 5 of VV
skin scarification, these cells had clearly been activated
originally in ILN draining the scarification site. Therefore,
it is likely that the gut-homing CD8+ T cells found in skin-
draining LN in the tumor model were originally activated
in gut-draining LN and had migrated into skin-homing
LN by day 4 of tumor injection. These cells maintained
their initial gut-homing imprinting in the skin-draining
LN, similar to what we have observed. Our observation
that at 60 hr after i.p. infection, OT-I cells activated in
ILN upregulated E-Lig but not a4b7 further demon-
strates that the homing phenotype of activated T cells
are regulated by LN-specific factors rather than the
route of antigen administration. However, unlike the
OT-I cells in our study, the tumor-specific T cells did
not appear to acquire secondary homing molecules in
the new LN microenvironment. The reasons underlying
these different observations are unclear. It is possible
that different time points used yielded different results.
It is also possible that the innate immune systemic in-
flammatory reactions associated with VV skin scarifica-
tion may contribute to the secondary homing imprinting
Immunity
518in distant LN by increasing the production of homing sig-
naling molecules.
Although trafficking of activated OT-I cells at early
stage of primary response correlated well with their
homing phenotype, we did not observe preferential
homing of E-Lig+ or a4b7+ effector OT-I cells into skin-
or gut-draining LN as reported previously (Mora et al.,
2005). Instead, the percentages of E-Lig+ and a4b7+
OT-I cells did not differ in various LN, suggesting that
different T cell subsets with heterogeneous homing phe-
notypes enter all LN equally well. However, the percent-
ages of homing-polarized (E-Lig+ or/and a4b7+) OT-I
cells were significantly higher in spleen than in LN, sug-
gesting relative preference of unpolarized T cells for LN
homing. By day 30 post infection, the percentages of
E-Lig+ or a4b7+ memory OT-I cells became significantly
lower than those of primary OT-I effector cells. This may
be due to the preferential homing and accumulation of
these polarized cells into peripheral tissues as tissue-
specific Tem.
Recent studies with parabiotic mouse model demon-
strated that memory T cells are highly mobile (Klonowski
et al., 2004). They migrate from immune mice to their
parabiotic naive partners and reach equilibrium in all
lymphoid and most peripheral tissues. Similarly, we ob-
served that while the OT-I cells were initially activated
and expanded only in regional LN at 60 hr after viral in-
oculation, their frequencies eventually reached equilib-
rium among different LN. Therefore, memory T cell mi-
gration is likely under homeostatic control to keep the
memory pool balanced among various tissues. Interest-
ingly, the predominant homing phenotype on the mem-
ory OT-I cells is the one imprinted during T cell priming.
The same finding was recapitulated in the low CTL pre-
cursor frequency setting. Our data suggest that the cel-
lular immune system not only remembers what antigens
it has encountered, but also where the antigens were in-
troduced. Since we have analyzed only memory cells in
lymphoid tissues, these results have not taken nonlym-
phoid tissues Tem cells into account. Whether the initial
homing imprinting is maintained on the extralymphoid
Tem subset remains to be investigated.
Finally, we have shown that compared to the unimmu-
nized mice, both i.p. immunized and skin-scarified mem-
ory mice were protected against secondary cutaneous
challenge. Importantly, at day 6 post challenge, while
more than 60% of the i.p. immunized group still had ac-
tive viral infection at challenged skin area, all the scarified
memory mice had completely cleared the virus from the
skin, even though the serum anti-VV antibody levels were
comparable between the two groups (data not shown).
These data strongly suggest that the ability to generate
large number of tissue-specific Tem by peripheral immu-
nization correlates with more effective protection of the
immunized tissue against secondary challenge. These
findings have important implications for the design of
vaccination strategies against pathogens that preferen-
tially invade host via certain target tissues.
Experimental Procedures
Mice, Viruses, and Viral Infection
All animal work was in compliance with the guidelines set out by the
Center for Animal Resources and Comparative Medicine at HarvardMedical School (HMS). Thy1.1+ OT-I mice were bred in a biosafety
level 1 (BL-1) facility at HMS. 6- to 8-week-old female Thy1.2+ B6J
mice were purchased from Jackson Laboratory and housed in
a BL-2 facility. rVV-ova and wild-type VV-WR were kind gifts from
Dr. Bernald Moss (National Institutes of Health, Bethesda, MD) (Nor-
bury et al., 2002). The virus stocks were expanded and tittered in
Hela cells and CV-1 cells (American Tissue Culture Company) by
standard procedures (Earl et al., 1998). Mice were infected with
the virus either by i.p. injection (2 3 106 pfu in 100 ml of PBS) or
by skin scarification (2 3 106 pfu in 5 ml of PBS). For scarifi-
cation, mice were anesthetized i.p. with 2,2,2 Tribromoethanol
(250 mg/kg, Sigma). 5 ml of diluted virus was applied to tail skin
1 cm from the base of the tail. The skin area was then gently
scratched 25 times with a 28 1/2 G needle.
Adoptive Transfer of OT-I Cells
Spleens and LN were harvested from 3- to 4-week-old Thy1.1+ OT-I
mice. Red blood cells (RBC) were lysed and single-cell suspension
was prepared. CD8+ T cells were isolated with the mouse CD8a+ T
cell isolation kit according to the manufacturer’s protocol (Miltenyl
Biotec). The purity of the isolated cells was >95% measured by
flow cytometry. Isolated CD8+ T cells displayed a naive T cell pheno-
type (CD62Lhigh, CD44low, CD11aint, E-Lig2, P-Lig2, a4b72, Figure 2A
and data not shown). The cells were then labeled with 5 mM CFSE
(Molecule Probes) at 37C for 10 min, washed three times, and intra-
venously transferred into Thy1.2+ recipient mice (6 3 106 cells per
mouse).
Antibodies and Flow Cytometry
The following mAbs were purchased from BD Pharmingen: FITC-
conjugated anti-Thy1.2 (53-2.1), PE-conjugated anti-a4b7
(DATK32), PerCP-conjugated anti-Thy1.1 (OX-7), APC-conjugated
anti-CD62L (MEL-14), and biotinylated anti-CD11a (2D7). For E-Lig
and P-Lig staining, lymphocytes were incubated with 5 mg/mL of
CD62E/Fc chimera or CD62P/Fc chimera (R&D systems) in HBSS
supplemented with 2 mM calcium, 5% FCS, and 1 mM HEPES buffer
for 30 min at 4C. Cells were then washed and incubated with bioti-
nylated goat F(ab)’;2 anti-human IgG (BD Bioscience) for 30 min at
4C followed by streptavidine-fluochrome and other cell-surface
marker staining. Since selectin-ligand binding was calcium depen-
dent, HBSS buffer supplemented with 5 mM EDTA instead of cal-
cium was used for specificity control for E-Lig and P-Lig staining.
Nonspecific binding to CD62E/Fc chimera or CD62P/Fc chimera
was lower than 5% of Thy1.1+ T cells (data not shown). Samples
were acquired with a FACSCalibur flow cytometer; data were ana-
lyzed with Flowjo software (Tree Star).
Immunohistochemistry Staining
Immunohistochemistry (IHC) was performed with 5 mm thick forma-
lin-fixed, paraffin-embedded tissue sections. In brief, slides were
soaked in xylene, passed through graded alcohols, and put in dis-
tilled water. Slides were then pretreated with 10 mM citrate (pH
6.0) (Zymed, South San Francisco, CA) in a steam pressure cooker
(Decloaking Chamber, BioCare Medical, Walnut Creek, CA) as per
the manufacturer’s instructions followed by washing in distilled wa-
ter. All further steps were performed at room temperature in a hy-
drated chamber. Slides were pretreated with peroxidase block
(DAKO USA, Carpinteria, CA) for 5 min to quench endogenous per-
oxidase activity. Primary rabbit anti-CD3 antibody (DAKO) was ap-
plied at a dilution of 1:250 in DAKO diluent for 1 hr. Slides were
washed in 50 mM Tris-Cl (pH 7.4) and detected with anti-rabbit
Envision+ kit (DAKO) as per the manufacturer’s instructions. After
further washing, immunoperoxidase staining was developed with
a DAB chromogen (DAKO) and counterstained with hematoxylin.
Real-Time RT-PCR to Detect VV Infection
Tissues harvested from rVV-ova-infected mice were immediately
snap-frozen in liquid nitrogen. RNA was extracted from these tis-
sues with Trizol reagent (Invitrogen) according to the manufacturer’s
instructions. The RNA samples were treated with DNase (Promega)
and reverse-transcribed with Oligo dT (Promega) and Omniscript RT
Kit (Qiagen) according to the manufacturer’s instructions. The cDNA
products were then mixed with Qiagen SYBR Green Reagent, and
the primers specific for a subunit of a VV DNA-directed RNA
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2004). The real-time PCR was performed with a Bio-Rad iCycler iQ
Real-Time PCR Detection System (Bio-Rad Laboratories, Inc. Her-
cules, CA). Thermal cycle conditions have been described previ-
ously (Howell et al., 2004). All PCR reactions included RT minus
RNA samples as the negative controls. The CT values for VV gene
were normalized to the housekeeper gene cyclophilin A (forward
primer, GTGGTCTTTGGGAAGGTGAA; reverse primer, TTACAGGA
CATTGCGAGCAG). The level of viral gene expression was normal-
ized to that in the skin samples of uninfected control mice.
FTY720 Treatment
FTY720 (provided by Dr. V. Brinkmann at Novartis Pharmaceuticals,
Basel, Switzerland) was dissolved in distilled water. Mice were in-
jected i.p. daily with FTY720 at dose of 1 mg/kg.
Real-Time PCR to Determine Viral Load
VV load was evaluated by quantitative real-time PCR. In brief, 6 days
after scarification, inoculated skin samples were harvested and DNA
was purified with the DNeasy Mini Kit (Qiagen, Valencia, CA) accord-
ing to the manufacture’s protocol. Real-time PCR was performed
with the Bio-Rad iCycler iQ Real-Time PCR Detection System (Bio-
Rad Laboratories). The primers and TagMan probe used in the quan-
titative PCR assay are specific for the ribonucleotide reductase
Vvl4L of VV. The sequences are (forward) 50-GAC ACT CTG GCA
GCC GAA AT-30; (reverse) 50-CTG GCG GCT AGA ATG GCA TA-30;
(probe) 50-AGC AGC CAC TTG TAC TAC ACA ACA TCC GGA-30.
The probe was 50-labeled with FAM and 30-labeled with TAMRA
(Applied Biosystems, Foster City, CA). Amplification reactions
were performed in a 96-well PCR plate (Bio-Rad Laboratory) in
a 20 ml volume containing 23 TaqMan Master Mix (Applied Biosys-
tems), 500 nM forward primer, 500 nM reverse primer, 150 nM probe,
and the template DNA. Thermal cycling conditions were 50C for
2 min and 95C for 10 min for one cycle, followed by 45 cycles of am-
plification (94C for 15 s and 60C for 1 min). To calculate the virus
load, a standard curve was established from DNA of a VV stock
with previously determined titer. Corresponding CT values obtained
by the real-time PCR methods were plotted on the standard curve to
estimate viral load in the skin samples.
Statistical Analysis
All statistical analyses were made with Microsoft Excel software
(Microsoft). Statistical comparisons between data sets were made
with a two-tailed homoscedastic Student’s t test.
Supplemental Data
Seven Supplemental Figures can be found with this article online at
http://www.immunity.com/cgi/content/full/25/3/511/DC1/.
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